Oral liposomal co-delivery of ultrasmall ceria and 5-aminosalicylic acid alleviates DSS colitis via ROS scavenging and microbiome remodeling

View at publisher Summarise with VIRAT
Authors: Jiahao Du, Yunyun Sun, Dong Yu, Shengwei Lu, Simin Yu, Mei Wang, 周国庆, Songxin Xu, Lei Zhang, Yefei Zhu, Longxiang Zhou
Cited by: 0
References: 58

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

. In a dextran sulfate sodium (DSS)-induced colitis model, CeLA alleviated clinical symptoms, restored intestinal barrier integrity, and suppressed pro-inflammatory cytokine expression. Notably, CeLA also reshaped the dysbiotic gut microbiome by reducing pro-inflammatory bacterial taxa. This multifunctional nanozyme integrates antioxidant, anti-inflammatory, and microbiome-modulating effects, offering a promising therapeutic strategy for IBD.

Fields of Study & Subjects

Inflammatory Bowel Disease Advanced Nanomaterials in Catalysis Advanced Drug Delivery Systems

Publication details

Journal / source
Journal of Materials Chemistry B
Volume
14
Issue
16
Pages
4956–4970
Publication date
29 April 2026
Language
EN